Influence of residual antegrade coronary blood flow on the long-term prognosis of medically treated patients with myocardial infarction and single-vessel disease

Japanese Heart Journal

Volumn 38, Issue 1, 1997, Pages 27-38

  Imamura, Hiroshi ^a   Nishiyama, Shinichiro ^b   Nakanishi, Shigemoto ^b   Seki, Akira ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Coronary artery bypass grafting (CABG); Coronary artery disease; Mortality; Percutaneous transluminal coronary angioplasty (PTCA); Reperfusion therapy; Survey

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030944398     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.38.27     Document Type: Article

References (27)

1. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase l Undings. N Engl J Med 1985; 312: 932-6.
2. Hartzier GO, Rutherford BD, McConahay DR. Percutaneous transluminal coronary angioplasty: application for acute myocardial infarction. Am J Cardiol 1984; 53: 17C-21C.
3. Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987; 317: 581-8.
4. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-401.
5. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
6. Ohman EM, Capiff RM, Topol EJ, et al. Consequence of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990; 82: 781-91.
7. Sabri MN, DiSciascio G, Cowley MJ, et al. Immediate and long-term results of delayed recanalization of occluded acute myocardial infarction-related arteries using coronary angioplasty. Am J Cardiol 1992; 69: 575-8.
8. White HD, Cross DB, Elliot JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994; 89: 61-7.
9. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333-9.
10. Varnauskas E, and the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the Randomized European Coronary Surgery- Study. N Engl J Med 1988; 319: 332-7.
11. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990; 82: 1629-46.
12. Osugi J, Takatsu F. Prognosis of medically treated coronary artery disease; correlation with angiographic findings. Coronary 1984; 1: 186-92.
13. Chino M, Yoshino H, Tani M, et al. Prognosis of medically treated coronary artery disease. Nippon Naika Gakkai Zasshi 1987; 76: 1033-1038, (in Japanese).
14. Saito M, Fukami K, Hiramori K, et al. Long-term prognosis of patients with acute myocardial infarction; Is mortality and morbidity as low as the incidence of ischemic heart disease in Japan? Am Heart J 1987; 113: 891-7.
15. Hosoda S, Iino T, Yasuda H, et al. Long-term follow-up of medically treated patients with coronary artery disease. I. Incidence of major cardiac events and its risk factors in Japanese with coronary artery disease. Jpn Circ J 1990; 54: 231-40.
16. Nishiyama S, Kato K, Nakanishi S, Seki A, Yamaguchi H. Long-term prognosis in 990 medically treated Japanese patients with coronary artery disease. Jpn Heart J 1993; 34: 539-50.
17. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Intarction (TIMI) trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
18. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the Coronary Artery Surgen- Study (CASS) registry. Circulation 1982; 66: 562-8.
19. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol 1989; 64: 155-60.
20. Trappe HJ, Lichtlen PR, Klein H, Wenzlaff P, Hartwig CA. Natural history of single vessel disease. Risk of sudden death in relation to coronary anatomy and arrhythmia profile. Eur Heart J 1989; 10: 514-24.
21. Dalen JE, Gore JM, Braunwald E, et al. Six- and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trial. Am J Cardiol 1988; 62: 179-85.
22. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75: 299-306.
23. Kersschot IE, Brugada P, Ramentol M, et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol 1986; 7: 1234-42.
24. Lange RA, Cigarroa RG, Wells PJ, Kremers MS, Hills LD. Influence of antegrade flow in the infarct artery on the incidence of late potentials after acute myocardial infarction. Am J Cardiol 1990; 65: 554- 8.
25. Dervan J, Briam DS, Cherniles J, Grossman W. Transluminal angioplasty of occluded coronary arteries: use of a movable guidewire system. Circulation 1983; 68: 776-84.
26. Nath A, DiSciascio G, Kelly KM, et al. Multivessel coronary angioplasty early after acute myocardial infarction. J Am Coll Cardiol 1990; 16: 545-50.
27. CASS Principal Investigators and their Associates. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 1984; 310: 750-8.